NEW COMPOUNDS AND METHODS
The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, optical isomer, N-oxide, and/or prodrug thereof. The present invention also relates to pharmaceutical compositions comprising the compounds of the invention, and to their use...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BALMOND, Edward I RACKHAM, Mark David RAWLING, Michael J SAVORY, Edward D FINN, Callum VASS, Márton PAUL, Rebecca |
| description | The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, optical isomer, N-oxide, and/or prodrug thereof. The present invention also relates to pharmaceutical compositions comprising the compounds of the invention, and to their use in the treatment or prevention of medical conditions in which inhibition of c-Abl is beneficial. (I) |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4028387A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4028387A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4028387A13</originalsourceid><addsrcrecordid>eNrjZJD0cw1XcPb3DfAP9XMJVnD0c1HwdQ3x8HcJ5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJgZGFsYW5o6GxkQoAQDRux-R</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NEW COMPOUNDS AND METHODS</title><source>esp@cenet</source><creator>BALMOND, Edward I ; RACKHAM, Mark David ; RAWLING, Michael J ; SAVORY, Edward D ; FINN, Callum ; VASS, Márton ; PAUL, Rebecca</creator><creatorcontrib>BALMOND, Edward I ; RACKHAM, Mark David ; RAWLING, Michael J ; SAVORY, Edward D ; FINN, Callum ; VASS, Márton ; PAUL, Rebecca</creatorcontrib><description>The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, optical isomer, N-oxide, and/or prodrug thereof. The present invention also relates to pharmaceutical compositions comprising the compounds of the invention, and to their use in the treatment or prevention of medical conditions in which inhibition of c-Abl is beneficial. (I)</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220720&DB=EPODOC&CC=EP&NR=4028387A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220720&DB=EPODOC&CC=EP&NR=4028387A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BALMOND, Edward I</creatorcontrib><creatorcontrib>RACKHAM, Mark David</creatorcontrib><creatorcontrib>RAWLING, Michael J</creatorcontrib><creatorcontrib>SAVORY, Edward D</creatorcontrib><creatorcontrib>FINN, Callum</creatorcontrib><creatorcontrib>VASS, Márton</creatorcontrib><creatorcontrib>PAUL, Rebecca</creatorcontrib><title>NEW COMPOUNDS AND METHODS</title><description>The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, optical isomer, N-oxide, and/or prodrug thereof. The present invention also relates to pharmaceutical compositions comprising the compounds of the invention, and to their use in the treatment or prevention of medical conditions in which inhibition of c-Abl is beneficial. (I)</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJD0cw1XcPb3DfAP9XMJVnD0c1HwdQ3x8HcJ5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJgZGFsYW5o6GxkQoAQDRux-R</recordid><startdate>20220720</startdate><enddate>20220720</enddate><creator>BALMOND, Edward I</creator><creator>RACKHAM, Mark David</creator><creator>RAWLING, Michael J</creator><creator>SAVORY, Edward D</creator><creator>FINN, Callum</creator><creator>VASS, Márton</creator><creator>PAUL, Rebecca</creator><scope>EVB</scope></search><sort><creationdate>20220720</creationdate><title>NEW COMPOUNDS AND METHODS</title><author>BALMOND, Edward I ; RACKHAM, Mark David ; RAWLING, Michael J ; SAVORY, Edward D ; FINN, Callum ; VASS, Márton ; PAUL, Rebecca</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4028387A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2022</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BALMOND, Edward I</creatorcontrib><creatorcontrib>RACKHAM, Mark David</creatorcontrib><creatorcontrib>RAWLING, Michael J</creatorcontrib><creatorcontrib>SAVORY, Edward D</creatorcontrib><creatorcontrib>FINN, Callum</creatorcontrib><creatorcontrib>VASS, Márton</creatorcontrib><creatorcontrib>PAUL, Rebecca</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BALMOND, Edward I</au><au>RACKHAM, Mark David</au><au>RAWLING, Michael J</au><au>SAVORY, Edward D</au><au>FINN, Callum</au><au>VASS, Márton</au><au>PAUL, Rebecca</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NEW COMPOUNDS AND METHODS</title><date>2022-07-20</date><risdate>2022</risdate><abstract>The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, optical isomer, N-oxide, and/or prodrug thereof. The present invention also relates to pharmaceutical compositions comprising the compounds of the invention, and to their use in the treatment or prevention of medical conditions in which inhibition of c-Abl is beneficial. (I)</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP4028387A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | NEW COMPOUNDS AND METHODS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T02%3A31%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BALMOND,%20Edward%20I&rft.date=2022-07-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4028387A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |